DRI Healthcare Trust Reports Third Quarter 2021 Results and Announces Increase to Quarterly Distribution
– Continued strong performance of core royalty assets – – Demonstrated growth strategy execution through two transactions valued at up to $185 million – – Quarterly distribution doubled to US$0.075 per unit – TORONTO, Nov. 8, 2021 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) today announced its results for […]
DRI Healthcare Trust to Host Third Quarter Earnings Call and Webcast on November 9, 2021
TORONTO, Oct. 25, 2021 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) announced today it will hold a conference call to discuss its 2021 third quarter financial results on Tuesday, November 9, 2021, at 8:30 a.m. ET. The Trust will report its financial results on Monday, November 8, 2021, after […]
DRI Healthcare Trust Announces US$200 Million Credit Facility
TORONTO, Oct. 22, 2021 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) announced today that a subsidiary of the Trust has entered into a credit agreement with a syndicate of banks regarding US$200 million of revolving credit facilities (“the Facilities”). An initial draw on the Facilities will be used to […]
DRI Healthcare Trust Announces Acceptance by TSX of Normal Course Issuer Bid
TORONTO, Sept. 30, 2021 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) announced today the acceptance by the Toronto Stock Exchange (the “TSX”) of the Trust’s Notice of Intention to make a normal course issuer bid (the “NCIB”). Pursuant to the NCIB, the Trust proposes to purchase, from time to time, if […]
DRI Healthcare Trust Announces Acquisition of Royalty on Oracea®
– Oracea® is the only branded oral prescription medication indicated for papulopustular rosacea – TORONTO, Sept. 30, 2021 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) today announced that a wholly-owned subsidiary of DRI has acquired a royalty interest in Oracea® for a net purchase price of US$46.4 million. “We are […]
CTI BioPharma and DRI Healthcare Trust Announce up to $135 Million Debt and Royalty Transaction
– Transaction to Fund Launch and Commercialization of Pacritinib in the United States This Year Pending FDA Approval, and Future Commercialization – SEATTLE and TORONTO, Aug. 25, 2021 /CNW/ – CTI BioPharma Corp. (Nasdaq: CTIC) (CTI) and DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (DRI) today announced transactions totaling up to $135 million in funding for […]
DRI Healthcare Trust to Host Conference Call to Discuss Transaction Announcement
– Conference call to be held Wednesday, August 25, 2021 at 1:30 pm ET – TORONTO, Aug. 25, 2021 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) announced today that it will be conducting a conference call to discuss the Trust’s previously announced debt and royalty transaction with CTI BioPharma Corp. […]
DRI Healthcare Trust Reports Second Quarter 2021 Results
– Quarter highlighted by strong performance from existing pharmaceutical products portfolio – TORONTO, Aug. 5, 2021 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) today announced its results for the quarter ended June 30, 2021. The Trust’s second quarter 2021 financial statements and Management’s Discussion & Analysis have been filed […]
DRI Healthcare Trust to Host Second Quarter Earnings Call and Webcast on August 6, 2021
TORONTO, July 26, 2021 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI” or “the Trust”) announced today it will hold a conference call to discuss its 2021 second quarter financial results on Friday, August 6, 2021, at 8:30 a.m. ET. The Trust will report its financial results on Thursday, August 5, 2021, after […]
DRI Healthcare Trust Reports First Quarter 2021 Results
– With IPO complete, Trust is focused on executing its business plan – TORONTO, May 10, 2021 /CNW/ – DRI Healthcare Trust (TSX: DHT.U) (TSX: DHT.UN) (“DRI” or “the Trust”) today announced its results for the period ended March 31, 2021. The Trust’s first quarter 2021 financial statements and Management’s Discussion & Analysis have been filed on […]